Transforming growth factor-β-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between smad proteins and activator protein-1

被引:21
作者
Herzer, Kerstin [2 ]
Grosse-Wilde, Anne [3 ]
Krammer, Peter H. [4 ]
Galle, Peter R. [2 ]
Kanzler, Stephan [1 ]
机构
[1] Leopoldina Clin, Dept Internal Med 2, D-97422 Schweinfurt, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Internal Med 1, D-6500 Mainz, Germany
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[4] German Canc Res Ctr, Div Immunogenet, D-6900 Heidelberg, Germany
关键词
D O I
10.1158/1541-7786.MCR-08-0073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor-(TGF-beta) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. We recently identified tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as an important mediator of TGF-beta-lnduced apoptosis in hepatoma cells. In this study, we have further explored the mechanism by which TGF-beta up-regulates TRAIL expression. The T-flanking region of the TRAIL gene was isolated and characterized. Deletion mutants of the T-untranslated region of the TRAIL gene revealed a region comprising nucleotides -1950 to -1100 responsible for TRAIL induction following treatment with TGF-beta. Within this region, we have identified an activator protein-1 (AP-1) site indispensable for TGF-beta-mediated induction of TRAIL. Activation of this AP-1 site is mediated by a JunD.FosB heterodimer. Expression of DNSmad4, DNJunD, or DNFosB significantly impairs TGF-beta-mediated activation of the TRAIL promoter. Furthermore, with tRNA interference targeting Smad4, junD, FosB, we could abolish TRAIL expression and, subsequently, TGF-beta-induced TRAIL-mediated apoptosis in hepatoma cells. Our results reveal a new AP-1 site within the TRAIL promoter functionally involved in TGF-beta-induced TRAIL expression and apoptosis in hepatomas and thus provide evidence for the underlying mechanism by which TGF-beta might regulate cell death in liver cancer.
引用
收藏
页码:1169 / 1177
页数:9
相关论文
共 26 条
[1]   THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1 [J].
ANGEL, P ;
HATTORI, K ;
SMEAL, T ;
KARIN, M .
CELL, 1988, 55 (05) :875-885
[2]   ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1 [J].
ANGEL, P ;
ALLEGRETTO, EA ;
OKINO, ST ;
HATTORI, K ;
BOYLE, WJ ;
HUNTER, T ;
KARIN, M .
NATURE, 1988, 332 (6160) :166-171
[3]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[4]   Transforming growth factor β and the liver [J].
Bissell, DM ;
Roulot, D ;
George, J .
HEPATOLOGY, 2001, 34 (05) :859-867
[5]  
HAGLUND RE, 1987, MOL CELL BIOCHEM, V73, P11
[6]   Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cells [J].
Herzer, K ;
Ganten, TM ;
Schulze-Bergkamen, H ;
Grosse-Wilde, A ;
Koschny, R ;
Krammer, PH ;
Walczak, H .
HEPATOLOGY, 2005, 42 (01) :183-192
[7]  
Hocevar BA, 2000, METH MOL B, V142, P97
[8]   Apoptosis and the liver [J].
Kanzler, S ;
Galle, PR .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (03) :173-184
[9]   AP-1 function and regulation [J].
Karin, M ;
Liu, ZG ;
Zandi, E .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :240-246
[10]   Smads bind directly to the Jun family of AP-1 transcription factors [J].
Liberati, NT ;
Datto, MB ;
Frederick, JP ;
Shen, X ;
Wong, C ;
Rougier-Chapman, EM ;
Wang, XF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :4844-4849